1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Why is rapamycin effective against Kaposi sarcoma? An analysis of molecular pathways reveals posttranslational silencing of PTEN
    Meeting Abstract

    Dittmer, D.; Roy, D.; Krown, S. E.; Damania, B.; AIDS Malignancy Consortium (AMC)
    Cancer Research (2011)

    Fulltext@MSK | Save
  • High-throughput functional profiling of dedifferentiated liposarcoma cell lines
    Meeting Abstract

    Banerji, S.; Barretina, J.; Crago, A.; Frederick, A.; Okamoto, M.; Weir, B.; Cowley, G.; Root, D.; Ladanyi, M.; Singer, S.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • MicroRNA-130b contributes to mesenchymal differentiation and leiomyosarcomagenesis
    Meeting Abstract

    Danielson, L.; Guijarro, M.; Zavadil, J.; Wei, J. J.; Levine, D.; Hernando, E.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Alleviation of cancer chemotherapeutic agent-induced toxicity by the synthetic panaxytriol analogues of Panax Ginseng
    Meeting Abstract

    Chou, T. C.; Dong, H. J.; Zhang, X. G.; Lei, X. G.; Danishefsky, S. J.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Therapeutic cure against five human xenograft tumors and strongly suppressed drug-resistant and refractory xenograft tumors in nude mice by the third generation epothilone: Iso-oxazole fludelone
    Meeting Abstract

    Chou, T. C.; Zhang, X. G.; Dong, H. J.; Danishefsky, S. J.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • A role for the chromatin remodeling protein CHD3 in ovarian cancer therapy response
    Meeting Abstract

    Cutter, N.; Banerjee, N.; Vigliotti, M.; Janevski, A.; Levine, D.; Dimitrova, N.; Lucito, R.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • The interaction between BRCA2 and DSS1 is crucial for homologous recombination through controlling protein localization
    Meeting Abstract

    Egashira, A.; Siaud, N.; Christ, N.; Morita, M.; Kakeji, Y.; Jasin, M.; Maehara, Y.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • CH5126766 is a novel allosteric inhibitor of MEK that prevents its phosphorylation by RAF
    Meeting Abstract

    Ishii, N.; Harada, N.; Sakamoto, H.; Matsuda, Y.; Tomii, Y.; Tachibana-Kondo, Y.; Miura, T.; Ohara, K.; Iikura, H.; Aoki, T.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • The impact of PI3K/Akt pathway inhibition upon the c-myb oncogene
    Meeting Abstract

    Ho, A. L.; Vasudeva, S. D.; Schwartz, G. K.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Role of post-translational modification of the RUNX2 transcription factor in osteosarcoma
    Meeting Abstract

    Ito, T.; Zhao, X. Y.; Suehara, Y.; Kawai, A.; Nimer, S. D.; Ladanyi, M.
    Cancer Research (2011)

    Fulltext@MSK | Save